Arcutis Biotherapeutics, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Arcutis Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Arcutis Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$39.1M, a 5.86% decline year-over-year.
  • Arcutis Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$182M, a 26.7% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$241M, a 20.1% increase from 2022.
  • Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$302M, a 46% decline from 2021.
  • Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2021 was -$207M, a 51.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$241M +$60.5M +20.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$302M -$95.1M -46% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 -$207M -$69.9M -51.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$137M -$93.5M -217% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$43.1M -$23.4M -119% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 -$19.7M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.